Daegu, South Korea · Founded 2023 · Privately Held (backing)
Developer of hemostatic medical devices designed to control bleeding in emergency and clinical environments. Inopharma is based in Daegu, South Korea and was founded in 2023. Its last reported valuation was $4.2 million in Apr 2026. It has raised $10,000.
Last reported valuation
$4.2M
Oct 2026
Priced at
—
Total raised
$10K
Last round
—
How much has Inopharma raised?
$10Kacross 0 recorded rounds
Free account
More of Inopharma with a free account
·Watch Inopharma: the Monday email on marks, rounds and moves